Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11748220rdf:typepubmed:Citationlld:pubmed
pubmed-article:11748220lifeskim:mentionsumls-concept:C0035687lld:lifeskim
pubmed-article:11748220lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:11748220lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:11748220lifeskim:mentionsumls-concept:C1421652lld:lifeskim
pubmed-article:11748220lifeskim:mentionsumls-concept:C1658578lld:lifeskim
pubmed-article:11748220pubmed:issue8lld:pubmed
pubmed-article:11748220pubmed:dateCreated2002-2-18lld:pubmed
pubmed-article:11748220pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:abstractTextOne hallmark of inflammation is the proliferation of bystander cells such as vascular smooth muscle cells (SMC), a process governed by growth factors and cytokines. Whereas cytokine induction of gene products promoting inflammation and proliferation is well characterized, little is known about the concomitant down-regulation of potentially counter-regulatory gene products in these cells. By employing the suppression subtractive hybridization-PCR technique, RNA isolated from rat aortic SMC treated with the cytokines interleukin-1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF alpha) was subtracted from RNA of control cells. Eleven genes were identified, the expression of which fell by 44-77%. One, the transcriptional repressor splicing factor-1 or zfm1, was characterized further. Antisense oligonucleotide suppression of zfm1 protein synthesis mimicked the stimulatory effects of IL-1 beta and TNF alpha on SMC proliferation and expression of the chemokine MCP-1 and the vascular cell adhesion molecule-1. Moreover, in an in vivo mouse model of atherosclerosis, zfm1 abundance was decreased in proliferating arterial SMC. These findings suggest a role for zfm1 in controlling both proliferation and expression of pro-inflammatory gene products in SMC. Therefore, cytokine-induced down-regulation of zfm1 expression may contribute to the pathogenesis of hyperproliferative inflammatory diseases.lld:pubmed
pubmed-article:11748220pubmed:languageenglld:pubmed
pubmed-article:11748220pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:citationSubsetIMlld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11748220pubmed:statusMEDLINElld:pubmed
pubmed-article:11748220pubmed:monthFeblld:pubmed
pubmed-article:11748220pubmed:issn0021-9258lld:pubmed
pubmed-article:11748220pubmed:authorpubmed-author:HeckerMarkusMlld:pubmed
pubmed-article:11748220pubmed:authorpubmed-author:CattaruzzaMar...lld:pubmed
pubmed-article:11748220pubmed:authorpubmed-author:SchäferKatrin...lld:pubmed
pubmed-article:11748220pubmed:issnTypePrintlld:pubmed
pubmed-article:11748220pubmed:day22lld:pubmed
pubmed-article:11748220pubmed:volume277lld:pubmed
pubmed-article:11748220pubmed:ownerNLMlld:pubmed
pubmed-article:11748220pubmed:authorsCompleteYlld:pubmed
pubmed-article:11748220pubmed:pagination6582-9lld:pubmed
pubmed-article:11748220pubmed:dateRevised2004-12-3lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:meshHeadingpubmed-meshheading:11748220...lld:pubmed
pubmed-article:11748220pubmed:year2002lld:pubmed
pubmed-article:11748220pubmed:articleTitleCytokine-induced down-regulation of zfm1/splicing factor-1 promotes smooth muscle cell proliferation.lld:pubmed
pubmed-article:11748220pubmed:affiliationDepartment of Cardiovascular Physiology, University of Göttingen, Humboldtallee 23, 37073 Göttingen, Germany.lld:pubmed
pubmed-article:11748220pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:114635entrezgene:pubmedpubmed-article:11748220lld:entrezgene
entrez-gene:114636entrezgene:pubmedpubmed-article:11748220lld:entrezgene
entrez-gene:114637entrezgene:pubmedpubmed-article:11748220lld:entrezgene
entrez-gene:117855entrezgene:pubmedpubmed-article:11748220lld:entrezgene
entrez-gene:293589entrezgene:pubmedpubmed-article:11748220lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11748220lld:pubmed